Protalix Biotherapeutics Inc (PLX) financials · rev $52.7M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Protalix Biotherapeutics Inc (PLX) rev $52.7M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $52.7M | $53.4M |
| Cost of Revenue | $27.0M | $24.3M |
| Gross Profit | $25.8M | $29.1M |
| Operating Income | -$5.50M | $3.92M |
| Net Income | -$6.60M | $2.93M |
| EPS (Diluted) | -$0.08 | $0.04 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $82.3M | $73.4M |
| Current Assets | $66.7M | $60.1M |
| Cash & Equivalents | $14.7M | $19.8M |
| Inventory | $25.7M | $21.2M |
| PP&E | $4.88M | $4.59M |
| Total Liabilities | $34.1M | $30.2M |
| Current Liabilities | $26.5M | $25.6M |
| Shareholders' Equity | $48.2M | $43.2M |
| Retained Earnings | -$385.0M | -$378.4M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$12.0M | $8.67M |
| CapEx | $1.64M | $1.28M |
| Investing Cash Flow | -$2.37M | $4.22M |
| Financing Cash Flow | $9.33M | -$16.8M |
| Net Change in Cash | -$5.08M | -$3.87M |
| Free Cash Flow | -$13.6M | $7.39M |
FAQ
What is PLX P/E and revenue?
Protalix Biotherapeutics Inc (PLX) rev $52.7M.
What is PLX revenue?
Protalix Biotherapeutics Inc last cached revenue is $52.7M (FY2025).
Is PLX profitable?
Protalix Biotherapeutics Inc last cached net income is -$6.60M (FY2025).
What are PLX total assets?
Protalix Biotherapeutics Inc last cached total assets are $82.3M (FY2025).
What is PLX free cash flow?
Protalix Biotherapeutics Inc last cached free cash flow is -$13.6M (FY2025).
Not investment advice. Cached statements, not a live tape.